Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel drug for treating cancer

A cancer and drug technology, applied in the field of drugs for the treatment of cancer, to achieve the effect of doubling efficiency, good effect and complementary advantages

Pending Publication Date: 2019-09-24
蔡海德
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

good for cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel drug for treating cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] (1) Goat seminal vesicles and seminal tubes are ground into a sterile freeze-dried powder with a particle size of less than 1 μm

[0027] Sheep seminal vesicles and seminal ducts: the weight ratio of 0°C normal saline is 1:0.5-1.0

[0028] Slurry freeze-dried powder 10g

[0029] (2) Natural royal jelly and water chestnut skin are ground into 1 μm particle size sterile freeze-dried powder

[0030] Royal jelly: ground to a particle size of less than 1 μm, water chestnut skin pulp with a weight ratio of 1:4 sterile freeze-dried powder

[0031] Water chestnut skin: the weight ratio of 10°C normal saline is 1:0.5-1.0

[0032] Grind into pulp 12g

[0033] (3) Appropriate amount of natural honey

[0034] Make honeyed pills that each diameter is 6mm.

[0035] The preparation method is the same as above.

Embodiment 2

[0037] (1) Goat seminal vesicles and seminal tubes are ground into a sterile freeze-dried powder with a particle size of less than 1 μm

[0038] Sheep seminal vesicles and seminal ducts: the weight ratio of 0°C normal saline is 1:0.5-1.0

[0039] Slurry freeze-dried powder 30g

[0040] (2) Natural royal jelly and water chestnut skin are ground into 1 μm particle size sterile freeze-dried powder:

[0041] Royal jelly: ground to a particle size of less than 1 μm, water chestnut skin pulp with a weight ratio of 1:4 sterile freeze-dried powder

[0042] Water chestnut skin: the weight ratio of 10°C normal saline is 1:0.5-1.0

[0043] Grind into pulp 36g

[0044] (3) Appropriate amount of natural honey

[0045] Make honeyed pills that each diameter is 6mm.

[0046] The preparation method is the same as above.

Embodiment 3

[0048] (1) Goat seminal vesicles and seminal tubes are ground into a sterile freeze-dried powder with a particle size of less than 1 μm

[0049] Sheep seminal vesicles and seminal ducts: the weight ratio of 0°C normal saline is 1:0.5-1.0

[0050] Slurry freeze-dried powder 19g

[0051] (2) Natural royal jelly and water chestnut skin are ground into 1 μm particle size sterile freeze-dried powder:

[0052] Royal jelly: ground to a particle size of less than 1 μm, water chestnut skin pulp with a weight ratio of 1:4 sterile freeze-dried powder

[0053] Water chestnut skin: 10°C physiological saline, the weight ratio is 1:0.5-1.0, ground into pulp, 25g

[0054] (3) Appropriate amount of natural honey

[0055] Make honeyed pills that each diameter is 6mm.

[0056] The preparation method is the same as above.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a novel drug for treating cancer, and relates to a cancer treatment drug. A mechanism of the novel drug is to improve the immunity of human bodies, through improvement of the self-healing power of the human bodies, cancer can be cured, and cytotoxicity does not exist, so that the bodies of patients can be fine without damage, and besides, the drug tolerance of cancer cells is not caused. The drug is good in cancer treatment effects. The novel anticancer drug adopts the raw materials in proportion by weight of 10g-30g of sheep seminal vesicle and semen pipe ground pulp bacteria-free freeze-dried powder, 12g-36g of natural royal jelly and water chestnut peel freeze-dried powder and an appropriate amount of natural honey. The substances are mixed, and then made into honeyed pills of which the diameters are 6mm or other oral preparations.

Description

technical field [0001] The invention relates to a medicine for treating cancer. [0002] technical background [0003] Most of the existing cancer treatment drugs are based on the mechanism of killing cancer cells, but while killing cancer cells, the drug toxicity will damage the patient's body, and due to drug cytotoxicity, cancer cells develop drug resistance, making it difficult to treat cancer cells. not effectively. Contents of the invention [0004] The present invention is a novel drug for treating cancer. One is to control cancer cells from transferring, spreading, and multiple occurrences; Improving the power and self-healing ability of the human body, stimulating the concentration, vitality and metabolism of the patient's own pluripotent stem cells in the blood to achieve drug control of cancer, autoimmunity and self-healing power relay to cure cancer, and repairing cancer cells from the patient's own pluripotent stem cells For normal cells, in this way, the fou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/89A61K9/20A61P35/00A61P37/04A61K35/52A61K35/644
CPCA61K35/52A61K35/644A61K36/89A61K9/2068A61P35/00A61P37/04A61K2300/00
Inventor 蔡海德
Owner 蔡海德
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products